Display options
Share it on

Cancers (Basel). 2021 Oct 11;13(20). doi: 10.3390/cancers13205078.

Recent Advances in the Management of Pediatric Acute Myeloid Leukemia-Report of the Hungarian Pediatric Oncology-Hematology Group.

Cancers

Zsuzsanna Gaál, Zsuzsanna Jakab, Bettina Kárai, Anikó Ujfalusi, Miklós Petrás, Krisztián Kállay, Ágnes Kelemen, Réka Simon, Gergely Kriván, Gábor T Kovács, Csongor Kiss, István Szegedi

Affiliations

  1. Department of Pediatric Hematology-Oncology, Institute of Pediatrics, University of Debrecen, 4032 Debrecen, Hungary.
  2. National Childhood Cancer Registry, 1094 Budapest, Hungary.
  3. Department of Laboratory Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  4. Division of Pediatric Hematology/Oncology, Velkey László Child's Health Center, 3526 Miskolc, Hungary.
  5. Pediatric Hematology and Stem Cell Transplantation Department, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, 1097 Budapest, Hungary.
  6. Second Department of Pediatrics, Semmelweis University, 1094 Budapest, Hungary.

PMID: 34680225 PMCID: PMC8534106 DOI: 10.3390/cancers13205078

Abstract

Outcome measures of pediatric acute myeloid leukemia (AML) improved considerably between 1990 and 2011 in Hungary. Since 2012, efforts of the Hungarian Pediatric Oncology-Hematology Group (HPOG) included the reduction in the number of treatment centers, contemporary diagnostic procedures, vigorous supportation, enhanced access to hematopoietic stem cell transplantation (HSCT), and to targeted therapies. The major aim of our study was to evaluate AML treatment results of HPOG between 2012 and 2019 with 92 new patients registered (52 males, 40 females, mean age 7.28 years). Two periods were distinguished: 2012-2015 and 2016-2019 (55 and 37 patients, respectively). During these periods, 2 y OS increased from 63.6% to 71.4% (

Keywords: Hungarian Pediatric Oncology-Hematology Group; acute myeloid leukemia; acute promyelocytic leukemia; multidimensional flow cytometry; survival outcomes

References

  1. Int J Hematol. 2009 Jan;89(1):86-90 - PubMed
  2. Front Pediatr. 2019 Oct 11;7:412 - PubMed
  3. Leukemia. 1997 Jul;11(7):1014-6 - PubMed
  4. Blood. 2018 Jul 26;132(4):405-412 - PubMed
  5. Haemophilia. 2017 Jul;23(4):e259-e266 - PubMed
  6. Blood. 2013 Jul 4;122(1):37-43 - PubMed
  7. Hematol Oncol Stem Cell Ther. 2017 Mar;10(1):35-38 - PubMed
  8. Transl Pediatr. 2014 Apr;3(2):156-82 - PubMed
  9. Blood. 1996 Feb 1;87(3):882-6 - PubMed
  10. Clin Chem Lab Med. 2011 Nov 04;50(2):301-10 - PubMed
  11. Blood. 2017 Jun 8;129(23):3051-3058 - PubMed
  12. Curr Opin Pediatr. 2020 Feb;32(1):57-66 - PubMed
  13. Blood. 2016 May 19;127(20):2391-405 - PubMed
  14. Best Pract Res Clin Haematol. 2014 Mar;27(1):69-78 - PubMed
  15. Leuk Lymphoma. 2019 Dec;60(13):3107-3115 - PubMed
  16. Cancer Epidemiol. 2018 Jun;54:19-24 - PubMed
  17. J Clin Oncol. 2015 Sep 20;33(27):2949-62 - PubMed
  18. Memo. 2013 Feb;6(1):54-62 - PubMed
  19. Leukemia. 2003 Dec;17(12):2318-57 - PubMed
  20. Haematologica. 2014 Aug;99(8):e127-9 - PubMed
  21. Memo. 2014;7(1):63-74 - PubMed
  22. Paediatr Drugs. 2017 Feb;19(1):1-10 - PubMed
  23. Lancet Oncol. 2010 Jun;11(6):543-52 - PubMed
  24. J Clin Oncol. 1990 May;8(5):813-9 - PubMed
  25. Blood. 2009 Jul 30;114(5):937-51 - PubMed
  26. Leukemia. 2019 Jun;33(6):1349-1359 - PubMed
  27. J Clin Oncol. 2006 Aug 1;24(22):3686-92 - PubMed
  28. Br Med J (Clin Res Ed). 1988 May 14;296(6633):1372-6 - PubMed
  29. Pediatr Blood Cancer. 2021 Jul;68(7):e28979 - PubMed
  30. Ann Hematol. 2019 Jun;98(6):1413-1420 - PubMed
  31. Leukemia. 2018 Oct;32(10):2167-2177 - PubMed

Publication Types